Prestige Consumer Healthcare
PBH
212 hedge funds and large institutions have $1.96B invested in Prestige Consumer Healthcare in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 90 increasing their positions, 71 reducing their positions, and 27 closing their positions.
41% more call options, than puts
Call options by funds: $339K | Put options by funds: $240K
27% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 71
1% more capital invested
Capital invested by funds: $1.94B → $1.96B (+$22M)
4% less funds holding
Funds holding: 221 → 212 (-9)
5.7% less ownership
Funds ownership: 125.24% → 119.53% (-5.7%)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
+$17.4M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$11.7M |
| 3 |
BlackRock
New York
|
+$6.38M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$5.43M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$61.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$36.3M |
| 3 |
JP Morgan Chase
New York
|
-$10.7M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$10.2M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$8.49M |
PBH Hedge Fund Activity: Q2 2019 in Review
212 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2019, worth a combined $1.96B — up 1.1% from $1.94B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of PBH and 21 opened new positions — a net loss of 6 holders — while 71 trimmed existing stakes and 90 added.
The largest buyer was Sterling Capital Management, adding an estimated $17.4M. The largest seller was Fidelity Investments, cutting an estimated $61.2M.
- 212 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2019, down from 221 in Q1 2019.
- Funds reported $1.96B of Prestige Consumer Healthcare stock for Q2 2019, up 1.1% quarter-over-quarter.
- 21 funds opened new Prestige Consumer Healthcare positions in Q2 2019 and 27 closed out, a net change of -6 holders.
- The largest Prestige Consumer Healthcare buyer in Q2 2019 was Sterling Capital Management, an estimated $17.4M added.
- The largest Prestige Consumer Healthcare seller in Q2 2019 was Fidelity Investments, an estimated $61.2M sold.
Based on aggregated 13F filings for Q2 2019.